6.
Krengli M, Masini L, Kaanders J, Maingon P, Oei S, Zouhair A
. Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases. A Rare Cancer Network study. Int J Radiat Oncol Biol Phys. 2006; 65(3):751-9.
DOI: 10.1016/j.ijrobp.2006.01.016.
View
7.
Gonzalez-Garcia R, Ruiz-Laza L, Roman-Romero L
. Lateral rhinotomy combined with anterior transantral approach for the treatment of large malignant melanoma of the nasal cavity involving the nasopharynx. J Craniomaxillofac Surg. 2011; 40(3):266-70.
DOI: 10.1016/j.jcms.2011.04.018.
View
8.
Sun S, Huang X, Gao L, Zhang Y, Luo J, Zhang S
. Long-term treatment outcomes and prognosis of mucosal melanoma of the head and neck: 161 cases from a single institution. Oral Oncol. 2017; 74:115-122.
DOI: 10.1016/j.oraloncology.2017.09.020.
View
9.
Wushou A, Zhao Y
. The management and site-specific prognostic factors of primary oral mucosal malignant melanoma. J Craniofac Surg. 2015; 26(2):430-4.
DOI: 10.1097/SCS.0000000000001328.
View
10.
Seetharamu N, Ott P, Pavlick A
. Mucosal melanomas: a case-based review of the literature. Oncologist. 2010; 15(7):772-81.
PMC: 3228004.
DOI: 10.1634/theoncologist.2010-0067.
View
11.
Henderson M, Burmeister B, Ainslie J, Fisher R, Di Iulio J, Smithers B
. Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial. Lancet Oncol. 2015; 16(9):1049-1060.
DOI: 10.1016/S1470-2045(15)00187-4.
View
12.
Lopez F, Rodrigo J, Cardesa A, Triantafyllou A, Devaney K, Mendenhall W
. Update on primary head and neck mucosal melanoma. Head Neck. 2014; 38(1):147-55.
PMC: 4986507.
DOI: 10.1002/hed.23872.
View
13.
Berzina A, Azarjana K, cema I, Pjanova D, Rivosh A
. Prognostic factors and epidemiological characteristics of cutaneous and mucosal head and neck melanoma. Stomatologija. 2011; 13(2):49-54.
View
14.
Burmeister B, Henderson M, Ainslie J, Fisher R, Di Iulio J, Smithers B
. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncol. 2012; 13(6):589-97.
DOI: 10.1016/S1470-2045(12)70138-9.
View
15.
Medina J, Ferlito A, Pellitteri P, Shaha A, Khafif A, Devaney K
. Current management of mucosal melanoma of the head and neck. J Surg Oncol. 2003; 83(2):116-22.
DOI: 10.1002/jso.10247.
View
16.
Stanienda-Sokol K, Salwowska N, Slawinska M, Wicherska-Pawlowska K, Lorenc A, Wcislo-Dziadecka D
. Primary Locations of Malignant Melanoma Lesions Depending on Patients’ Gender and Age. Asian Pac J Cancer Prev. 2017; 18(11):3081-3086.
PMC: 5773794.
DOI: 10.22034/APJCP.2017.18.11.3081.
View
17.
Wright F, Souter L, Kellett S, Easson A, Murray C, Toye J
. Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline. Curr Oncol. 2019; 26(4):e541-e550.
PMC: 6726255.
DOI: 10.3747/co.26.4885.
View
18.
Patrick R, Fenske N, Messina J
. Primary mucosal melanoma. J Am Acad Dermatol. 2007; 56(5):828-34.
DOI: 10.1016/j.jaad.2006.06.017.
View
19.
Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F
. Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. JAMA Dermatol. 2022; 158(5):495-503.
PMC: 8968696.
DOI: 10.1001/jamadermatol.2022.0160.
View
20.
Song H, Wu Y, Ren G, Guo W, Wang L
. Prognostic factors of oral mucosal melanoma: histopathological analysis in a retrospective cohort of 82 cases. Histopathology. 2015; 67(4):548-56.
DOI: 10.1111/his.12692.
View